Publications by authors named "Frances Prelli"

Claim this Profile
P
Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer's Mouse Model With Tau Pathology.
Allal Boutajangout, Wei Zhang, Justin Kim, Wed Ali Abdali, Frances Prelli

Front Aging Neurosci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease.
Eleanor Drummond, Fernando Goñi, Shan Liu, Frances Prelli, Henrieta Scholtzova

J Alzheimers Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Krystal Herline, Frances Prelli, Pankaj Mehta, Claire MacMurray, Fernando Goñi

Alzheimers Res Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.
Fernando Goñi, Mitchell Martá-Ariza, Krystal Herline, Daniel Peyser, Allal Boutajangout, Frances Prelli

Alzheimers Res Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline.
Shan Liu, Shinae Park, Grant Allington, Frances Prelli, Yanjie Sun

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Fluorescent Probe for Detection of Aβ Oligomers.
Chai Lean Teoh, Dongdong Su, Srikanta Sahu, Seong-Wook Yun, Eleanor Drummond, Frances Prelli

J Am Chem Soc· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Styryl-based and tricyclic compounds as potential anti-prion agents.
Erika Chung, Frances Prelli, Stephen Dealler, Woo Sirl Lee, Young-Tae Chang

PLoS One· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease.
Fernando Goñi, Frances Prelli, Yong Ji, Henrieta Scholtzova, Jing Yang

PLoS One· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo.
Martin J Sadowski, Joanna Pankiewicz, Frances Prelli, Henrieta Scholtzova, Daryl S Spinner

Neurobiol Dis· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insights into the cure of prion disease by novel antiprion compounds.
Sarah Webb, Tamuna Lekishvili, Corinna Loeschner, Shane Sellarajah, Frances Prelli

J Virol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease.
Gianluigi Zanusso, Alberto Polo, Alessia Farinazzo, Romolo Nonno, Franco Cardone, Frances Prelli

Arch Neurol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
Martin J Sadowski, Joanna Pankiewicz, Henrieta Scholtzova, Pankaj D Mehta, Frances Prelli

Proc Natl Acad Sci U S A· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies on the first described Alzheimer's disease amyloid beta mutant, the Dutch variant.
Efrat Levy, Frances Prelli, Blas Frangione

J Alzheimers Dis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
Joanna Pankiewicz, Frances Prelli, Man-Sun Sy, Richard J Kascsak, Regina B Kascsak

Eur J Neurosci· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification of human wild-type or variant cystatin C from conditioned media of transfected cells.
Frances Prelli, Monika Pawlik, Blas Frangione, Efrat Levy

Methods Mol Biol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes.
Gianluigi Zanusso, Alessia Farinazzo, Frances Prelli, Michele Fiorini, Matteo Gelati

J Biol Chem· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copper chelation delays the onset of prion disease.
Einar M Sigurdsson, David R Brown, Muhammad A Alim, Henrieta Scholtzova, Richard Carp, Frances Prelli

J Biol Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme.
Laura Morelli, Ramiro Llovera, Silvia A Gonzalez, Jose L Affranchino, Frances Prelli

J Biol Chem· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis